Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry
Hironori Kitabata(Wakayama Medical University), Takashi Akasaka(Sakurabashi Watanabe Hospital), Yoshihiro Morino(Iwate Medical University), Kavitha M. Chinnaiyan(Beaumont Hospital, Royal Oak), Manesh R. Patel(Duke University), Niels Peter Rønnow Sand(University of Southern Denmark), Bjarne Linde Nørgaard(Aarhus University), Tomohiro Kawasaki(Koga Hospital), Tetsuya Amano(Aichi Medical University), Campbell Rogers(HeartFlow (United States)), Bernard De Bruyne(Al-Azhar University), Jeroen J. Bax(Leiden University), Koen Nieman(University of British Columbia), Mark Rabbat(Loyola University Chicago), Philipp Blanke(University of British Columbia), Gianluca Pontone(University of Milan), Gilbert Raff, Hitoshi Matsuo, Timothy Fairbairn(University of Liverpool), Jonathon Leipsic(University of British Columbia)
Cited by 43
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k